Invitae Corporation (NVTAQ)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 10:25AM EDT. Market open.
| Previous close | 0.0006 |
| Open | 0.0004 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0004 - 0.0006 |
| 52-week range | 0.0001 - 1.6600 |
| Volume | |
| Avg. volume | 2,552,163 |
| Market cap | 171,895 |
| Beta (5Y monthly) | 1.52 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Labcorp Announces Winning Bid for Select Assets of Invitae
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company. Before the transaction can proceed, the court overseeing the process must issue an approval order following a hearing currently scheduled for May 6, 2024.
- PR Newswire
Invitae Publishes its Environmental, Social and Governance (ESG) Report
Invitae (OTC: NVTA), a leading medical genetics company, today published its 2024 Environmental, Social and Governance (ESG) Report. This report provides a holistic view of the company's approach to ESG and its performance and progress through measurable data and metrics during the 2023 fiscal year.
© 2024 Yahoo. All rights reserved.